These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4143952)

  • 21. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L; Vecchi L
    Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
    [No Abstract]   [Full Text] [Related]  

  • 22. Structural-functional organization of the human brain and the pathophysiology of the Parkinsonian type hyperkineses.
    Bechtereva NP; Bondartchuk AN; Gretchin VB; Iliukhina VA; Kambarova DK; Matveev YK; Petushkov EP; Pozdeev VK; Smirnov VM; Shandurina AN
    Confin Neurol; 1972; 34(2):14-7. PubMed ID: 4579785
    [No Abstract]   [Full Text] [Related]  

  • 23. Towards systemic theories in biological psychiatry.
    Bender W; Albus M; Möller HJ; Tretter F
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S4-9. PubMed ID: 16508889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical signalling in the globus pallidus in parkinsonism.
    Brotchie J; Crossman A; Mitchell I; Duty S; Carroll C; Cooper A; Henry B; Hughes N; Maneuf Y
    Prog Brain Res; 1993; 99():125-39. PubMed ID: 7906423
    [No Abstract]   [Full Text] [Related]  

  • 25. Identify the specific role of regional changes for the complex symptoms of schizophrenia.
    Tretter F; Müller WE; Carlsson A
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S1-2. PubMed ID: 16508887
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural-functional organization of the human brain and the pathophysiology of the Parkinsonian type hyperkineses.
    Bechtereva NP; Bondartchuk AN; Gretchin VB; Iliukhina VA; Kambarova DK; Matveev YK; Petushkov EP; Pozdeev VK; Smirnov VM; Shandurina AN
    Confin Neurol; 1972; 34(1):14-7. PubMed ID: 4563544
    [No Abstract]   [Full Text] [Related]  

  • 27. Concurrent session: current trends in neurology and psychiatry.
    Med J Aust; 1971 Oct; 2(14):Suppl 5:42-4. PubMed ID: 5165477
    [No Abstract]   [Full Text] [Related]  

  • 28. Symposium on stereotaxic operations in extrapyramidal disturbances organized by the Netherlands Society of Neurosurgeons held in Groningen (The Netherlands), 15 November, 1969. Introduction.
    van Manen J
    Psychiatr Neurol Neurochir; 1970; 73(5):325-8. PubMed ID: 4926420
    [No Abstract]   [Full Text] [Related]  

  • 29. Contributions of functional imaging to understanding parkinsonian symptoms.
    Grafton ST
    Curr Opin Neurobiol; 2004 Dec; 14(6):715-9. PubMed ID: 15582373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles.
    Opacka-Juffry J; Brooks DJ
    Mov Disord; 1995 May; 10(3):241-9. PubMed ID: 7651438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disinhibition as an organizing principle in the nervous system. The role of gamma-aminobutyric acid.
    Roberts E
    Adv Neurol; 1974; 5():127-43. PubMed ID: 4155229
    [No Abstract]   [Full Text] [Related]  

  • 32. [Normal and pathological sleep. Clinical and experimental cases in relation to catecholamines during the use of L-Dopa].
    Delmar A; Kuziora IF; Pozzo R; D'Alberto N; Di Marco M
    Prensa Med Argent; 1970 Oct; 57(35):1649-53. PubMed ID: 4396056
    [No Abstract]   [Full Text] [Related]  

  • 33. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilites for the future.
    Hornykiewicz OD
    Neurology; 1970 Dec; 20(12):Suppl:1-5. PubMed ID: 5529913
    [No Abstract]   [Full Text] [Related]  

  • 34. Chairman's introduction: role of the pallidum and its transmitters in the therapy of parkinsonian rigidity and akinesia.
    Hassler RG
    Adv Neurol; 1984; 40():1-14. PubMed ID: 6141708
    [No Abstract]   [Full Text] [Related]  

  • 35. Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease.
    Klockgether T; Turski L
    Trends Neurosci; 1989 Aug; 12(8):285-6. PubMed ID: 2475945
    [No Abstract]   [Full Text] [Related]  

  • 36. Brainstem interactions with the basal ganglia.
    Redgrave P; Coizet V
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S301-5. PubMed ID: 18267254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distributed disturbances in brain structure and function in schizophrenia.
    Lewis DA
    Am J Psychiatry; 2000 Jan; 157(1):1-2. PubMed ID: 10618005
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 39. A combined neurochemical and neurophysiological approach to identification of central nervous system transmitters.
    Aprison MH; Werman R
    Neurosci Res (N Y); 1968; 1(0):143-74. PubMed ID: 4152429
    [No Abstract]   [Full Text] [Related]  

  • 40. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.